VANDA PHARMACEUTICALS INC. Stock-Based Compensation
VANDA PHARMACEUTICALS INC. (VNDA) reported Stock-Based Compensation of $4.67 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-06
- VANDA PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $2.11M, a 0.05% increase year-over-year.
- VANDA PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $2.56M, a 13.73% decline year-over-year.
- VANDA PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $2.29M, a 20.19% decline year-over-year.
- VANDA PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $2.11M, a 29.58% decline year-over-year.
- VANDA PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for fiscal 2025 was $9.47M, a 23.79% decline from fiscal 2024.
- VANDA PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for fiscal 2024 was $12.43M, a 11.45% decline from fiscal 2023.
- VANDA PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for fiscal 2023 was $14.04M, a 13.75% decline from fiscal 2022.
- VANDA PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for fiscal 2022 was $16.28M, a 5.89% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $4.67M 10-Q · filed 2026-08-06 | $6.96M derived: sum of 3 quarters · filed 2026-08-06 | $9.07M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $2.56M 10-Q · filed 2026-05-07 | $4.85M derived: sum of 2 quarters · filed 2026-05-07 | $6.96M derived: sum of 3 quarters · filed 2026-05-07 | $9.07M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $4.40M derived: sum of 2 quarters · filed 2026-02-12 | $6.50M derived: sum of 3 quarters · filed 2026-08-06 | $9.47M 10-K · filed 2026-02-12 | ||||
| 2025-09-30 | $2.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $4.22M derived: sum of 2 quarters · filed 2026-08-06 | $7.19M 10-Q · filed 2025-10-30 | $10.05M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $2.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $5.08M 10-Q · filed 2026-08-06 | $7.94M derived: sum of 3 quarters · filed 2026-08-06 | $10.94M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $2.97M 10-Q · filed 2026-05-07 | $5.83M derived: sum of 2 quarters · filed 2026-05-07 | $8.83M derived: sum of 3 quarters · filed 2026-05-07 | $11.82M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $2.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $5.86M derived: sum of 2 quarters · filed 2026-02-12 | $8.85M derived: sum of 3 quarters · filed 2026-02-12 | $12.43M 10-K · filed 2026-02-12 | ||||
| 2024-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $5.99M derived: sum of 2 quarters · filed 2025-10-30 | $9.57M 10-Q · filed 2025-10-30 | $12.84M derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-06-30 | $2.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $6.57M 10-Q · filed 2025-07-31 | $9.84M derived: sum of 3 quarters · filed 2026-02-12 | $13.01M derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-03-31 | $3.58M 10-Q · filed 2025-05-08 | $6.86M derived: sum of 2 quarters · filed 2026-02-12 | $10.02M derived: sum of 3 quarters · filed 2026-02-12 | $13.27M derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2023-12-31 | $3.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $6.44M derived: sum of 2 quarters · filed 2026-02-12 | $9.69M derived: sum of 3 quarters · filed 2026-02-12 | $14.04M 10-K · filed 2026-02-12 | ||||
| 2023-09-30 | $3.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $6.42M derived: sum of 2 quarters · filed 2024-11-07 | $10.77M 10-Q · filed 2024-11-07 | $14.55M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2023-06-30 | $3.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $7.60M 10-Q · filed 2024-08-01 | $11.38M derived: sum of 3 quarters · filed 2025-02-14 | $15.27M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2023-03-31 | $4.35M 10-Q · filed 2024-05-09 | $8.13M derived: sum of 2 quarters · filed 2025-02-14 | $12.02M derived: sum of 3 quarters · filed 2025-02-14 | $15.85M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2022-12-31 | $3.78M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $7.67M derived: sum of 2 quarters · filed 2025-02-14 | $11.50M derived: sum of 3 quarters · filed 2025-02-14 | $16.28M 10-K · filed 2025-02-14 | ||||
| 2022-09-30 | $3.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $7.72M derived: sum of 2 quarters · filed 2023-11-09 | $12.50M 10-Q · filed 2023-11-09 | $16.27M derived: sum of 4 quarters · filed 2024-02-08 | ||||
| 2022-06-30 | $3.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $8.61M 10-Q · filed 2023-07-28 | $12.38M derived: sum of 3 quarters · filed 2024-02-08 | $16.33M derived: sum of 4 quarters · filed 2024-02-08 | ||||
| 2022-03-31 | $4.78M 10-Q · filed 2023-05-03 | $8.55M derived: sum of 2 quarters · filed 2024-02-08 | $12.50M derived: sum of 3 quarters · filed 2024-02-08 | $16.24M derived: sum of 4 quarters · filed 2024-02-08 | ||||
| 2021-12-31 | $3.77M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08 | $7.72M derived: sum of 2 quarters · filed 2024-02-08 | $11.46M derived: sum of 3 quarters · filed 2024-02-08 | $15.37M 10-K · filed 2024-02-08 | ||||
| 2021-09-30 | $3.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $7.69M derived: sum of 2 quarters · filed 2022-11-03 | $11.60M 10-Q · filed 2022-11-03 | $14.81M derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2021-06-30 | $3.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $7.65M 10-Q · filed 2022-08-04 | $10.86M derived: sum of 3 quarters · filed 2023-02-09 | $14.00M derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2021-03-31 | $3.91M 10-Q · filed 2022-05-06 | $7.12M derived: sum of 2 quarters · filed 2023-02-09 | $10.26M derived: sum of 3 quarters · filed 2023-02-09 | $13.32M derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2020-12-31 | $3.21M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | $6.35M derived: sum of 2 quarters · filed 2023-02-09 | $9.42M derived: sum of 3 quarters · filed 2023-02-09 | $13.36M 10-K · filed 2023-02-09 | ||||
| 2020-09-30 | $3.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $6.20M derived: sum of 2 quarters · filed 2021-11-04 | $10.15M 10-Q · filed 2021-11-04 | $13.82M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | $3.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $7.01M 10-Q · filed 2021-07-29 | $10.68M derived: sum of 3 quarters · filed 2022-02-24 | $14.09M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | $3.94M 10-Q · filed 2021-05-06 | $7.61M derived: sum of 2 quarters · filed 2022-02-24 | $11.02M derived: sum of 3 quarters · filed 2022-02-24 | $14.12M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | $3.67M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $7.08M derived: sum of 2 quarters · filed 2022-02-24 | $10.18M derived: sum of 3 quarters · filed 2022-02-24 | $13.46M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | $3.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $6.51M derived: sum of 2 quarters · filed 2020-10-29 | $9.79M 10-Q · filed 2020-10-29 | $12.71M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-06-30 | $3.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $6.38M 10-Q · filed 2020-08-06 | $9.30M derived: sum of 3 quarters · filed 2021-02-11 | $12.18M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-03-31 | $3.28M 10-Q · filed 2020-05-07 | $6.20M derived: sum of 2 quarters · filed 2021-02-11 | $9.08M derived: sum of 3 quarters · filed 2021-02-11 | $11.80M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2018-12-31 | $2.92M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $5.79M derived: sum of 2 quarters · filed 2021-02-11 | $8.52M derived: sum of 3 quarters · filed 2021-02-11 | $11.67M 10-K · filed 2021-02-11 | ||||
| 2018-09-30 | $2.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $5.59M derived: sum of 2 quarters · filed 2019-11-07 | $8.74M 10-Q · filed 2019-11-07 | $11.53M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-06-30 | $2.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $5.87M 10-Q · filed 2019-08-01 | $8.65M derived: sum of 3 quarters · filed 2020-02-26 | $11.43M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-03-31 | $3.15M 10-Q · filed 2019-05-03 | $5.93M derived: sum of 2 quarters · filed 2020-02-26 | $8.70M derived: sum of 3 quarters · filed 2020-02-26 | $11.36M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2017-12-31 | $2.78M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $5.55M derived: sum of 2 quarters · filed 2020-02-26 | $8.21M derived: sum of 3 quarters · filed 2020-02-26 | $10.46M 10-K · filed 2020-02-26 | ||||
| 2017-09-30 | $2.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $5.43M derived: sum of 2 quarters · filed 2018-11-07 | $7.68M 10-Q · filed 2018-11-07 | $9.79M derived: sum of 4 quarters · filed 2019-02-19 | ||||
| 2017-06-30 | $2.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $4.91M 10-Q · filed 2018-08-02 | $7.01M derived: sum of 3 quarters · filed 2019-02-19 | $9.12M derived: sum of 4 quarters · filed 2019-02-19 | ||||
| 2017-03-31 | $2.26M 10-Q · filed 2018-05-02 | $4.36M derived: sum of 2 quarters · filed 2019-02-19 | $6.46M derived: sum of 3 quarters · filed 2019-02-19 | $8.53M derived: sum of 4 quarters · filed 2019-02-19 | ||||
| 2016-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $4.20M derived: sum of 2 quarters · filed 2019-02-19 | $6.28M derived: sum of 3 quarters · filed 2019-02-19 | $8.54M 10-K · filed 2019-02-19 | ||||
| 2016-09-30 | $2.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $4.17M derived: sum of 2 quarters · filed 2017-11-08 | $6.44M 10-Q · filed 2017-11-08 | $8.33M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-06-30 | $2.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $4.34M 10-Q · filed 2017-08-03 | $6.23M derived: sum of 3 quarters · filed 2018-02-15 | $8.29M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-03-31 | $2.27M 10-Q · filed 2017-05-03 | $4.15M derived: sum of 2 quarters · filed 2018-02-15 | $6.21M derived: sum of 3 quarters · filed 2018-02-15 | $8.28M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2015-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $3.95M derived: sum of 2 quarters · filed 2018-02-15 | $6.02M derived: sum of 3 quarters · filed 2018-02-15 | $7.96M 10-K · filed 2018-02-15 | ||||
| 2015-09-30 | $2.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $4.13M derived: sum of 2 quarters · filed 2016-11-03 | $6.07M 10-Q · filed 2016-11-03 | $7.71M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-06-30 | $2.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $4.01M 10-Q · filed 2016-07-28 | $5.64M derived: sum of 3 quarters · filed 2017-02-17 | $7.05M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-03-31 | $1.95M 10-Q · filed 2016-05-05 | $3.58M derived: sum of 2 quarters · filed 2017-02-17 | $4.99M derived: sum of 3 quarters · filed 2017-02-17 | $6.43M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2014-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $3.04M derived: sum of 2 quarters · filed 2017-02-17 | $4.49M derived: sum of 3 quarters · filed 2017-02-17 | $5.88M 10-K · filed 2017-02-17 | ||||
| 2014-09-30 | $1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $2.85M derived: sum of 2 quarters · filed 2015-11-04 | $4.25M 10-Q · filed 2015-11-04 | $5.65M derived: sum of 4 quarters · filed 2016-02-12 | ||||
| 2014-06-30 | $1.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | $2.84M 10-Q · filed 2015-07-31 | $4.24M derived: sum of 3 quarters · filed 2016-02-12 | $5.81M derived: sum of 4 quarters · filed 2016-02-12 | ||||
| 2014-03-31 | $1.39M 10-Q · filed 2015-05-07 | $2.80M derived: sum of 2 quarters · filed 2016-02-12 | $4.37M derived: sum of 3 quarters · filed 2016-02-12 | $5.50M derived: sum of 4 quarters · filed 2016-02-12 | ||||
| 2013-12-31 | $1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $2.97M derived: sum of 2 quarters · filed 2016-02-12 | $4.11M derived: sum of 3 quarters · filed 2016-02-12 | $5.40M 10-K · filed 2016-02-12 | $4.60M 10-K · filed 2014-02-25 | |||
| 2013-09-30 | $1.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-27 | $2.70M derived: sum of 2 quarters · filed 2014-10-27 | $4.00M 10-Q · filed 2014-10-27 | $3.32M 10-Q · filed 2013-11-08 | $5.87M derived: sum of 4 quarters · filed 2015-03-13 | |||
| 2013-06-30 | $1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $2.43M 10-Q · filed 2014-08-08 | $1.78M 10-Q · filed 2013-07-31 | $4.31M derived: sum of 3 quarters · filed 2015-03-13 | $4.88M derived: sum of 4 quarters · filed 2015-03-13 | |||
| 2013-03-31 | $1.30M 10-Q · filed 2014-05-08 | $952.00K 10-Q · filed 2013-05-10 | $3.17M derived: sum of 2 quarters · filed 2015-03-13 | $3.75M derived: sum of 3 quarters · filed 2015-03-13 | $4.94M derived: sum of 4 quarters · filed 2015-03-13 | |||
| 2012-12-31 | $1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $2.45M derived: sum of 2 quarters · filed 2015-03-13 | $3.65M derived: sum of 3 quarters · filed 2015-03-13 | $5.05M 10-K · filed 2015-03-13 | $4.09M 10-K · filed 2013-02-26 | |||
| 2012-09-30 | $576.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $1.77M derived: sum of 2 quarters · filed 2013-11-08 | $3.17M 10-Q · filed 2013-11-08 | $4.49M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | $1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31 | $2.60M 10-Q · filed 2013-07-31 | $3.91M derived: sum of 3 quarters · filed 2014-02-25 | $5.17M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | $1.40M 10-Q · filed 2013-05-10 | $2.72M derived: sum of 2 quarters · filed 2014-02-25 | $3.97M derived: sum of 3 quarters · filed 2014-02-25 | $5.30M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $2.57M derived: sum of 2 quarters · filed 2014-02-25 | $3.90M derived: sum of 3 quarters · filed 2014-02-25 | $5.50M 10-K · filed 2014-02-25 | ||||
| 2011-09-30 | $1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $2.58M derived: sum of 2 quarters · filed 2012-11-08 | $4.18M 10-Q · filed 2012-11-08 | $5.52M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-06-30 | $1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $2.93M 10-Q · filed 2012-08-03 | $4.26M derived: sum of 3 quarters · filed 2013-02-26 | $5.15M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-03-31 | $1.60M 10-Q · filed 2012-05-09 | $2.94M derived: sum of 2 quarters · filed 2013-02-26 | $3.83M derived: sum of 3 quarters · filed 2013-02-26 | |||||
| 2010-12-31 | $1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $2.22M derived: sum of 2 quarters · filed 2013-02-26 | $4.98M 10-K · filed 2013-02-26 | |||||
| 2010-09-30 | $887.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $3.65M 10-Q · filed 2011-11-07 | ||||||
| 2010-06-30 | $2.76M 10-Q · filed 2011-08-05 | |||||||
| 2009-12-31 | $11.23M 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |